News
-
-
-
-
PRESS RELEASE
Medios sets out Ambition 2031: €3.1 billion revenue and a doubling of EBITDA adjusted
Medios reveals Ambition 2031 to achieve €3.1 billion revenue and double EBITDA by focusing on core business models: Specialty Pharma Supply and Compounding. Strategy emphasizes operational excellence and growth through M&A -
-
PRESS RELEASE
Christoph Prusseit will not extend his term on the Management Board beyond the current term
Christoph Prusseit, Chief Business Officer of Medios AG, will not extend Management Board term due to personal reasons. Supervisory Board expresses gratitude for his contributions and commitment -
-
-
-
PRESS RELEASE
Medios Acquires a 74% Majority Stake in Caelo and Strengthens Its German and European Business in Active Pharmaceutical Ingredients and Excipients
Medios AG acquires a 74% majority stake in Caelo, enhancing its European pharmaceutical ingredients and excipients business with broader offerings for pharmacies